Skip to content
    Sectoral Asset Management logo

    Sectoral Asset Management

    Montreal, CanadaFounded 2000
    www.sectoral.comLinkedIn
    HealthcareBiotech & Life Sciences

    Sectoral Asset Management is an SEC-registered investment advisor exclusively focused on the global healthcare sector, managing both public equity and late-stage venture capital strategies. Founded in 2000 and headquartered in Montreal, the firm's NEMO family of funds invests in innovative biotech and medtech companies at the clinical stage.

    Deal activity increased 67% year-over-year (5 deals in the last 12 months). Average disclosed round size is $59.7M (across 31 rounds with reported amounts).

    Find people at Sectoral Asset Management on Goldilocks AI

    Portfolio

    36

    Fund Size

    $150M

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    FB

    FRANÇOIS BEAUBIEN, Ph.D., CFA

    Partner

    AB

    ANTOINE BLONDIN

    Regional Director – Europe

    AA

    AREK ALSZKO

    Director of Information Technology

    BG

    Brett Goodin

    Director Australia

    HR

    HOWARD RIBACK

    Director, Venture Capital

    YZ

    YINGDONG ZHANG

    Regional Director - Asia

    GS

    GAUTHIER SANZ

    Senior Analyst

    JM

    JONATHAN MA

    Operations Analyst

    TM

    TOBY MA, Ph.D., CFA

    Financial Analyst

    AE

    ADIL ESSAKHI

    Systems Administrator

    CP

    CATHERINE PROTOPOULOS

    Senior Accountant

    FP

    FREDERIC PFUND

    Marketing Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    39 investments
    CompanyRoundAmountDate
    Route 92 Medical logoRoute 92 MedicalGrowth$50MApr 2026
    AAntegrade MedicalSeed$7.3MOct 2025
    SecondWave Systems logoSecondWave SystemsSeries A$7MOct 2025
    Neuros Medical logoNeuros MedicalSeries D$56MJul 2025
    Neuros logoNeurosSeries D$56MJul 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MMar 2025
    IIantrekSeries C—Jan 2025
    Neuros logoNeurosUnknown$56MJan 2025
    AAntegrade MedicalSeed—Jan 2025
    Evommune logoEvommuneSeries C$115MOct 2024
    EEVOMMUNE INC.Series C$115MOct 2024
    Phagenesis logoPhagenesisSeries D—Mar 2024
    Noctrix logoNoctrixSeries C$40MJan 2024
    LENZ Therapeutics logoLENZ TherapeuticsSeries B$83.5MJan 2023
    CurvaFix logoCurvaFixSeries C$39MJan 2023
    LLENZ Therapeutics, Inc.Series B$83.5MJan 2023
    Mineralys Therapeutics logoMineralys TherapeuticsSeries B$118MJun 2022
    Magnolia Medical Technologies logoMagnolia Medical TechnologiesGrowth$46MFeb 2022
    MMineralysSeries B$118MJan 2022
    MMineralys Therapeutics, Inc.Series B$118MJan 2022
    Turnstone Biologics logoTurnstone BiologicsSeries D$80MJul 2021
    MMineralysSeries A$40MApr 2021
    PPipeline TherapeuticsSeries C$110MJan 2021
    HHighLifeSeries B—Jan 2019
    Aprea Therapeutics logoAprea TherapeuticsSeries C—Nov 2018
    Page 1 of 2

    Top Co-Investors

    Andera Partners7 shared
    EQT Life Sciences7 shared
    RA Capital Management7 shared
    Versant Ventures7 shared
    Sofinnova Partners6 shared
    Samsara BioCapital5 shared
    Ysios Capital4 shared
    Rock Springs Capital4 shared
    Catalys Pacific4 shared
    U.S. Venture Partners4 shared
    Aperture Venture Partners4 shared
    RTW Investments, LP3 shared
    Pivotal Life Sciences3 shared
    Alpha Wave Global3 shared
    Adams Street Partners3 shared
    SR One3 shared
    Amzak Health3 shared
    Osage University Partners3 shared
    F-Prime Capital3 shared
    HBM Healthcare Investments3 shared

    Last updated: 8 September 2026